Engflag

Kali Bromatum

Quick links to important sections

Kali Bromatum

Kali Bromatum_P

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Kali Bromatum

Quick Facts

Property Description
Active Ingredient Potassium Bromide (KBr)
Form Powder, Oral Solution, Tablet, Homoeopathic Dilution
Pharmacological Class Central Nervous System (CNS) Depressant
General Purpose Calming the nervous system, reducing nervous excitability
Origin Synthetic (Inorganic Chemical Compound)

What is Kali Bromatum (Potassium Bromide) and Its Classification?

Kali Bromatum is the traditional Latin designation for the chemical compound Potassium Bromide (KBr), which is a synthetic inorganic salt known for its sedative properties. This compound is fundamentally classified as a Central Nervous System (CNS) Depressant and a Sedative-Hypnotic agent and historically served as a legacy anticonvulsant. The compound holds significant historical importance, being clinically recognized as one of the earliest effective antiepileptic agents used in human medicine since the mid-19th century. Its identity as a simple, single-ingredient compound is crucial for understanding its unique position in pharmaceutical history.

Composition, Origin, and Available Forms

The active substance in Kali Bromatum is the Potassium Bromide salt, which is entirely synthetic in origin and owes its therapeutic effects solely to the bromide ion (Br-) component. This ion's action promotes the generalized dampening of CNS activity. This single-entity compound is prepared for oral administration and is found in several dosage forms, including dissolvable powder, ready-to-use aqueous solution, and compressed tablet forms. A distinctive feature is its continued use in veterinary medicine, where Potassium Bromide remains a well-established and supported treatment option for seizure control. A highly diluted preparation of the compound is also recognized and utilized as a specific homoeopathic remedy under the name Kali Bromatum.

General Purpose: How Does It Calm the Nervous System?

The general purpose of Kali Bromatum is to stabilize brain activity and calm the nervous system by reducing the overall excitability of nerve cells. The bromide ion achieves this by promoting neuronal hyperpolarization, a process that makes nerve cells less responsive and consequently slows down the spontaneous firing of neurons throughout the CNS. The general principle of this pharmacological action is typically applied when there is a need to reduce persistent symptoms of excessive nervous tension and agitation by restoring a more stable, less reactive state to the central nervous system.

Regulatory References

  1. Bromide Action, MedlinePlus

What side effects are possible with Kali Bromatum?

Regulatory Safety Overview

The ingredient Potassium Bromide (Kali Bromatum) is often marketed in the United States as an unapproved homeopathic drug product. Regulatory documentation, such as the labeling published by the National Institutes of Health (NIH), includes a prominent Disclaimer from the U.S. Food and Drug Administration (FDA) which states: “This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.”

Adverse Reaction and Safety Information

Adverse reactions are not generally classified by frequency (e.g., Common, Rare) or by System-Organ Class in the high-level regulatory summaries for this homeopathic preparation. Most safety guidance centers on conditions that necessitate discontinuation or consultation with a health professional.

  • Serious Adverse Reactions: No specific serious adverse reactions are typically itemized in the regulatory summaries for this product category. However, under standard frameworks for drug reporting, any reaction that requires hospitalization, is life-threatening, causes a birth defect or disability, or results in death must be reported.
  • Exposure-Related Patterns: Users are directed to stop use and seek assistance from a health professional if symptoms persist for more than 3 days or worsen.

Population-Specific Considerations

Specific cautions are noted for certain populations:

  • Pregnancy and Breast-feeding: A health professional must be consulted before using this product if pregnant or breast-feeding.

Note on the Safety Profile: The official safety labeling structures the understanding of potential risks primarily through general precautionary statements related to symptom persistence and use in vulnerable populations. The fundamental safety context is established by the mandatory disclaimer regarding the lack of regulatory evaluation for the product’s safety and efficacy.

Overdose and Emergency Response

Overdose is primarily documented as Bromism, a toxicity syndrome resulting from the slow, chronic accumulation of the bromide ion, often associated with serum bromide levels above the therapeutic range. Manifestations of Bromism typically include neurological signs such as ataxia, confusion, slurred speech, lethargy, somnolence, and, in severe cases, profound CNS depression progressing to coma. Psychiatric disturbances like schizophreniform psychosis and the characteristic skin rash known as bromoderma are also documented. Diagnostic laboratory findings include pseudohyperchloremia and a negative anion gap.

Regulators mandate that immediate medical attention be sought for the onset of unexplained disturbance of consciousness or generalized epileptic seizures. Urgent help is also required for severe clinical escalations, including signs of cerebral edema or significant fluid loss. No specific pharmacological antidote is known for bromide toxicity. Management is supportive and procedural, focusing on accelerating bromide excretion. This is typically achieved through the administration of intravenous 0.9% sodium chloride solution. Hemodialysis may be required in life-threatening scenarios, particularly in patients with reduced kidney function and the elderly who are at heightened risk for bromide accumulation.

Therapeutic Uses of Kali Bromatum

What Kali Bromatum Treats: Main Uses and Benefits

The therapeutic relevance of Kali Bromatum is used in situations involving certain distressing symptoms, offering support across various symptom domains linked to heightened physiological activity. The medication is historically and currently applied to support neurological control in specific seizure disorders (epilepsy), including severe forms of generalized tonic-clonic and myoclonic seizures, particularly in pediatric and refractory cases. In these contexts, bromide is considered relevant for the management of severe epilepsy. Its use may assist with easing the burden of these involuntary neurological symptoms, which contributes to maintaining a sense of stability when symptoms are more noticeable.

Kali Bromatum is also commonly used to manage symptoms related to heightened physiological activity and distress, such as persistent worry, intense apprehension, or melancholy rooted in nervous turmoil. This provides support that helps ease the overall symptom burden and contributes to improved comfort during periods of tension. Furthermore, the compound is relevant for easing symptoms like insomnia and night terrors when they are caused by a hyperactive, restless mind, or when patients experience symptoms of increased neurological or muscular activity like persistent fidgeting or twitching. Its application also extends to certain persistent skin conditions such as specific patterns of acne and psoriasis, particularly when these eruptions are observed in individuals with an easily agitated constitution.

Summary of Therapeutic Uses

The overall patient benefit supports patients during difficult episodes by easing distress and maintaining a sense of stability.

“The overall patient benefit supports patients during difficult episodes by easing distress and maintaining a sense of stability.”

Quick Fact: Relief for Nervous Symptoms
Supports the management of Seizure symptoms and psychological distress
Applied during Periods of heightened nervous tension and agitation
Main benefit Contributes to improved comfort and functional stability

Regulatory References

  1. Great Ormond Street Hospital for Children NHS Foundation Trust

Eligibility and Restrictions for Use

The official regulatory information for over-the-counter (OTC) homeopathic products containing Kali Bromatum (Potassium Bromide) defines eligibility based on age, physiological status, and the presence of inert ingredients.

Official Eligibility Constraints

Population Group Regulatory Status / Constraint
Pregnant or Breast-feeding Individuals Must ask a health professional before use.
Pediatric Population Generally permitted for use by children and infants, but with age-specific instructions for administration.
Individuals with Sensitivities Excluded from use if sensitive to the inactive ingredients, which typically include lactose and sucrose in pellet or tablet formulations.

Regulatory Context

Official government labeling, such as that monitored by the U.S. Food and Drug Administration (FDA) via DailyMed, permits the use of this preparation by adults and children but places a mandatory constraint on use during pregnancy and lactation, requiring consultation with a health professional. Unlike formally approved medicines, these preparations are marketed as "unapproved homeopathic" drugs, meaning they lack an FDA determination of safety and efficacy. No formal, absolute contraindications are listed in the examined official labeling, but eligibility is restricted by the necessity of tolerating common excipients like lactose and sucrose.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Potassium Bromide (Kali Bromatum) around two primary concerns: managing enhanced central nervous system effects and controlling drug exposure levels.

Drug–Drug and Drug–Substance Interactions

Interacting Entity Interaction Type Officially Documented Outcome
CNS Depressants (e.g., Phenobarbital) Pharmacodynamic Synergism Co-administration is officially noted to cause enhanced or additive CNS depressant effects, increasing the risk of sedation.
Loop Diuretics (e.g., Furosemide) Exposure Modification Documented to decrease serum bromide concentrations by increasing the urinary excretion of the bromide ion.
Dietary Salt/Chloride (Food Content) Renal Clearance Competition High chloride intake leads to decreased serum concentrations, while low chloride intake causes increased serum concentrations, raising the risk of accumulation.

Restrictions and Considerations

The clearance mechanism, which relies on competitive reabsorption with the chloride ion in the kidneys, establishes the fundamental restriction that any substance or condition altering the body's chloride balance can modify systemic drug exposure. This includes dietary salt content, which must be considered due to its documented effect on clearance. No explicit mandatory timing separation rules are documented in the prescribing information.

Furthermore, official notes specify that clearance is reduced in populations with renal insufficiency, establishing an elevated risk of bromide accumulation and subsequent toxicity in those patients.

Mechanism of Action

The pharmacodynamic action of Kali Bromatum is mediated primarily by the bromide ion ( Br^-), which is selectively concentrated within the central nervous system (CNS). The bromide ion acts as an allosteric modulator of the inhibitory neurotransmitter system. Its primary molecular targets are the GABA-A receptors and neuronal chloride channels.

Br^- competes with chloride ions ( Cl^-) for transport across the neuronal membrane, leading to an increase in intracellular Br^- concentration. This cellular accumulation facilitates the actions of gamma-aminobutyric acid (GABA), the chief inhibitory neurotransmitter. The increased inhibitory signaling leads to greater hyperpolarization of the postsynaptic neuronal membrane, causing the membrane potential to become more negative relative to the firing threshold. The downstream cascade involves a reduction in overall neuronal excitability and stabilization of neuronal membranes, resulting in a systemic CNS depressant effect and decreased synaptic transmission.

Dosage and Administration Information

How to Use Kali Bromatum (Potassium Bromide)

Instructions for the use of Kali Bromatum (Potassium Bromide, KBr) are established for specific applications, including veterinary use and homeopathic formulations. This guidance outlines the required administration procedures.

Administration Protocol

Parameter Instruction
Route of Administration The primary route is oral (ingestion). For homeopathic pellet formulations, the route is sublingual (dissolved under the tongue).
Dosage Schedule Doses are administered on a daily frequency, typically once or twice per day, depending on the specific regimen. Veterinary maintenance doses range from 50 to 80 mg/kg of body weight daily.
Timing and Intake Tablets and solutions should be administered with food to minimize potential gastrointestinal irritation. Homeopathic pellets are dissolved under the tongue three times daily until symptoms improve.
Population-Specific Rules Dosage adjustments are required for certain patient groups. For patients with renal impairment, the starting dose must be significantly reduced, and serum levels require close monitoring. In pediatric homeopathic use, the dose is half the adult amount.
Special Procedural Conditions Treatment requires a long duration, often up to three months, to reach steady therapeutic blood levels. Patients must avoid abrupt changes in dietary chloride intake and the administration of chloride-containing intravenous fluids as these factors can substantially decrease serum bromide concentrations.

This protocol defines the standardized sequence for administering the medicine, including necessary adjustments for specific populations and critical constraints related to diet and fluid management.

Recent Clinical Evidence

Kali Bromatum: Recent Clinical Evidence

Kali Bromatum (Potassium Bromide) is a salt compound with a history of use in medicine dating back to the 19th century, particularly as an antiepileptic and sedative agent. Its use in human medicine has largely decreased due to the development of newer treatments with more favorable side effect profiles. However, recent clinical research continues to investigate its specialized uses, particularly within pediatric and complementary health settings.

Studies on Epilepsy and Neurological Conditions

Potassium Bromide (KBr) is an established anti-seizure medication in veterinary medicine. In human clinical studies, KBr is occasionally used to manage refractory epilepsy in children—seizure disorders that do not respond adequately to standard treatments. One study evaluating KBr for pediatric refractory epilepsy reported that it was associated with improvements in seizure control for over half of the children with generalized and focal epilepsy types. This evidence suggests a role for KBr in highly specific, treatment-resistant cases, particularly those involving tonic or generalized tonic-clonic seizures.

Exploratory Studies: Dermatological and Complementary Use

In the realm of complementary and alternative medicine, Kali Bromatum has been the subject of smaller, non-conventional studies focusing on dermatological conditions. Case reports and small clinical trials have been published examining its application for acne vulgaris in adolescents and adults. For instance, some studies using individualized treatment protocols have reported observations of good to moderate improvement in acne severity scores.

  • Caution: These dermatological studies typically involve homeopathic preparations of Kali Bromatum, which have not been evaluated for safety or efficacy by major regulatory bodies. The FDA is generally unaware of scientific evidence supporting homeopathy as effective.

Safety and Toxicity

Research emphasizes that KBr has a narrow therapeutic index and requires careful monitoring due to the risk of bromism, which can present with neuropsychiatric symptoms, confusion, lethargy, and an acne-like skin rash (bromoderma). Its long half-life necessitates protracted observation if toxicity is suspected.

Key Studies & References

  1. Potassium Bromide in the Treatment of Pediatric Refractory Epilepsy
  2. Bromine and Bromism: What's Old Is New Again (Review of Neuropsychiatric Symptoms)

Frequently Asked Questions (FAQ)

Common questions about Kali Bromatum (FAQ)

Q: What is Kali Bromatum used for?

According to the official product information for this homeopathic medicine, it is used for the temporary relief of certain symptoms. These indicated uses typically include conditions such as sleeplessness with agitation and forms of acne. These claims are based on traditional homeopathic practice and are not subject to FDA evaluation for effectiveness.

Q: Can I use this product if I am pregnant or breastfeeding?

The regulatory documents include a warning for use during pregnancy or while breastfeeding. Official labeling advises that a health professional should be consulted before using this product under these circumstances. This is a standard precaution listed in the product's safety information.

Q: How should I store Kali Bromatum?

The official product information directs that Kali Bromatum should be stored in a cool, dark place. Following this instruction helps maintain the product’s quality.

Q: Is it safe to use this long-term?

The regulatory label includes a 'Stop Use' warning to be followed if symptoms persist for more than three days or worsen. This instruction implies that the product is intended for short-term use. If symptoms are chronic or do not improve quickly, consulting a healthcare professional is generally recommended.

Q: Can children use this product?

Some official product labels provide dosing information for children who are 2 years of age and older. Before administering any medication to children, consulting a healthcare professional is generally recommended.

How should Kali Bromatum be stored and disposed of?

How to Store and Dispose of Kali Bromatum

Official regulatory labeling dictates specific conditions for storing and handling Kali Bromatum products to preserve quality and ensure safety.

Storage Requirements

Condition Requirement
Environment Must be stored in a cool dark place to protect the product from light and moisture. Some formulations must be stored below 25 C and kept tightly sealed.
Child Safety Mandatory instruction to keep this and all medication out of reach of children.
Container Integrity The container must be kept closed tightly after use. Do not use the product if the capseal is broken or missing.
In-Use Stability For certain tablet forms, the shelf life after opening is limited to 3 months. Halved tablets must be used within 12 hours.

Disposal Instructions

Disposal of any unused or expired Kali Bromatum must be carried out according to local regulations for medicinal waste. Environmental precautions require preventing spills from entering drains or water courses.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Kali Bromatum found in:

A-Z Index: